Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SZT2 antisense RNA 1 (SZT2-AS1) is a non-coding RNA transcribed antisense to the SZT2 gene locus. As an antisense RNA, it is likely to have a regulatory role in gene expression, potentially via cis- or trans-acting mechanisms such as RNA interference, modulation of transcription, or chromatin remodeling, but its exact function is not currently characterized in the literature. There is no evidence that this molecule is a protein or a therapeutic target like a receptor, enzyme, or transporter, and no disease roles or drug interactions are reported. Its annotation follows naming conventions for non-coding antisense transcripts. Notes and rationale: - There is no evidence that SZT2-AS1 encodes a protein or serves as a direct therapeutic target (such as a receptor, enzyme, transporter, or well-characterized signaling molecule). - SZT2-AS1 describes an antisense transcript at the SZT2 locus, which itself encodes a protein involved in seizure threshold, but the antisense RNA (SZT2-AS1) is non-coding and has not been described as a target in disease or drug development literature. - Thus, *is_target* is **false** and *is_incorrect* is **true** for use as a conventional drug target molecule. - Biological function entries and mechanism of action are based on general properties of antisense non-coding RNAs, not SZT2-AS1 specifically, pending further research. If you need structured information for **SZT2** protein (the sense transcript and protein-coding gene involved in epilepsy and mTOR regulation instead), that is a valid therapeutic target and can be detailed separately.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SZT2 antisense RNA 1 (non-protein coding) (SZT2-AS1).